| Name | GSK |
|---|---|
| Epic | GSK |
| Isin | GB00BN7SWP63 |
| Index | UK100 UK350 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 1,574.50p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £65,263.99 | Debt ratio | n/a |
| Shares in issue | 4,144.96 | Debt-to-equity ratio | n/a |
| P/E ratio | 9.4 | Assets / equity ratio | n/a |
| Total dividends per share | 58.00p | Price to book value | n/a |
| Dividend yield | 2.9 | ROCE | 67.14 |
| Dividend cover | 3.69 | EPS growth | 11 |
| Earning per share | 121.6 | 52-week high / low | 1,382.00p / 1,812.50p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| Q4 | 2024-02-22 | 2024-04-11 | 16.00p |
| Q3 | 2023-11-16 | 2024-01-11 | 14.00p |
| Q2 | 2023-08-17 | 2023-10-12 | 14.00p |
| Q1 | 2023-05-18 | 2023-07-13 | 14.00p |
| Q4 | 2023-02-23 | 2023-04-13 | 13.75p |
| Q3 | 2022-11-17 | 2023-01-12 | 13.75p |
| Q2 | 2022-08-18 | 2022-10-06 | 16.25p |
| Q1 | 2022-05-19 | 2022-07-01 | 14.00p |
| Q4 | 2022-02-24 | 2022-04-07 | 23.00p |
| Company name | GSK |
|---|---|
| Address | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS |
| Telephone | +44 (0)20 8047 5000 |
| Website | http://www.gsk.com |
| Director | Position |
|---|---|
| Ms Emma Walmsley | CEO |
| Mr Hal Barron | Non-Executive Director |
| Dr Jeannie Lee | Non-Executive Director |
| Mr Wendy Becker | Non-Executive Director |
| Mr Jonathan Symonds | Non-Executive Chairman |
| Mr Charles Bancroft | Senior Independent Non-Executive Director |
| Ms Julie Brown | Chief Finance Officer |
| Mr Harry (Hal) C. Dietz | Independent Non-Executive Director |
| Mr Vishal Sikka | Independent Non-Executive Director |
| Mr Elizabeth (Liz) McKee Anderson | Independent Non-Executive Director |
| Dr Anne Beal | Independent Non-Executive Director |
| Dr Jesse Goodman | Independent Non-Executive Director |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | 21579 | 21364 | 40631 |
| Investments and other non-current assets | 1192 | 1541 | 2214 |
| Total non-current assets | 40361 | 39377 | 60429 |
| Inventory / work in progress | 5498 | 5146 | 5783 |
| Trade and other receivables | 7385 | 7053 | 7860 |
| Cash and equivalents | 2936 | 3723 | 4274 |
| Other current assets and asset held for resale | 579 | 693 | 696 |
| Total of all assets | 59005 | 60146 | 79103 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 21068 | 22810 | 23670 |
| Long term liabilities | 25142 | 27240 | 34091 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 46210 | 50050 | 57761 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 12795 | 10096 | 21342 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 1348 | 1347 | 1347 |
| Minority interests | -552 | -502 | 6287 |
| Retained earnings | 7239 | 4363 | 7944 |
| Share premium account | 3451 | 3440 | 3301 |
| Total equity | 12795 | 10096 | 21342 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | 6745 | 6433 | 4357 |
| Pre-tax profit | 6064 | 5628 | 3599 |